AntimalarialsLupus Erythematosus, SystemicLupus NephritisArtemisininsChloroquinePlasmodium falciparumParasitic Sensitivity TestsMefloquineMalariaQuinineMalaria, FalciparumSesquiterpenesDrug ResistanceFluorenesSulfadoxinePyrimethaminePlasmodium cynomolgiPhenanthrenesPlasmodiumTetraoxanesDrug CombinationsProguanilAmodiaquineParasitemiaSelf MedicationTanzaniaHydroxychloroquinePlasmodium bergheiQuinolinesEthanolaminesTrophozoitesLupus Erythematosus, DiscoidBlackwater FeverSpiro CompoundsAntibodies, AntinuclearDosage FormsPeroxidesPrimaquineInhibitory Concentration 50Protozoan ProteinsAtovaquoneErythrocytesDapsoneHemeproteinsDrug DiscoveryFeverDrug Therapy, CombinationAsia, SoutheasternFolic Acid AntagonistsDrug Evaluation, PreclinicalCambodiaParasitesCase ManagementAutoantibodiesNigeriaSudanKenyaUgandaAminoquinolinesMalaria, VivaxPregnancy Complications, ParasiticMice, Inbred NZBPlasmodium vivaxNaphthyridinesThailandMice, Inbred MRL lprTabletsLife Cycle StagesDrug Resistance, MultipleTetrahydrofolate DehydrogenaseHemeMolecular StructureMembrane Transport ProteinsHealth PolicyAfricaStructure-Activity RelationshipAntibodies, AnticardiolipinHemoglobinsAntibodies, AntiphospholipidTreatment OutcomeDrug DesignDNA, ProtozoanAntiphospholipid SyndromeCross-Sectional StudiesAutoantigensDrug InteractionsImmunoglobulin GAnti-Bacterial AgentsAutoimmune DiseasesAutoimmunity